Status:
COMPLETED
Monitoring of Biopsy-Proven Interstitial Polyomavirus Nephritis in Kidney and Kidney Pancreas Transplant Recipients
Lead Sponsor:
University of Cincinnati
Conditions:
Polyomavirus
Eligibility:
All Genders
18-70 years
Brief Summary
Evaluate techniques for monitoring the course of interstitial therapy for polyomavirus nephritis in kidney and kidney pancreas transplant recipients by monitoring blood, urine, and renal transplant bi...
Detailed Description
Evaluate techniques for monitoring the course of interstitial therapy for polyomavirus nephritis in kidney and kidney pancreas transplant recipients by monitoring blood, urine, and renal transplant bi...
Eligibility Criteria
Inclusion
- Recipients of a kidney or kidney pancreas transplant diagnosed with biopsy proven interstitial nephritis due to polyomavirus.
- Age 18 to 70 years.
- Capable of providing written informed consent.
Exclusion
- Age less than 18 years or greater than 70 years.
- Patient is on chronic warfarin or heparin therapy or has a disease that puts them at risk of bleeding.
Key Trial Info
Start Date :
June 1 2001
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2007
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00374283
Start Date
June 1 2001
End Date
October 1 2007
Last Update
January 3 2008
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
The Christ Hospital
Cincinnati, Ohio, United States, 45267
2
University of Cincinnati
Cincinnati, Ohio, United States, 45267